- $83.5 BnWorld market, 2023
- $121.2 BnProjected, 2033
- 3.8%Growth a year (CAGR)
- 395Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$35.1 Bn
1.8% a year · 42% of the world -
2
China
$6.7 Bn
5.3% a year · 8% of the world -
3
Canada
$6.7 Bn
3.8% a year · 8% of the world -
4
Japan
$5.2 Bn
4.3% a year · 6.2% of the world -
5
Germany
$3.1 Bn
2% a year · 3.7% of the world -
6
France
$2.3 Bn
2.8% a year · 2.8% of the world -
7
UK
$2.2 Bn
1.8% a year · 2.6% of the world -
8
Brazil
$2.1 Bn
4.8% a year · 2.5% of the world -
9
Italy
$2 Bn
3.3% a year · 2.4% of the world -
10
Ecuador
$1.7 Bn
4.4% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
Spain
AustraliaHealthcare In Vitro Diagnostic by country and region
India
Saudi Arabia
Mexico
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Singapore
Thailand
Kenya
New Zealand
Russia"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 1,117 papers since 2021
- AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium. Molecular therapy. Advances, 2026
- Protein nanocages: Programmable biomaterial platforms for therapeutics, bioimaging, and diagnostics. Acta biomaterialia, 2026
- Decoding Luciferase Signal Dynamics: A Roadmap to Reliable Luminescent Assays. JACS Au, 2026
- From spreadsheets and scripts to controlled software lifecycles: recommendations for laboratory-developed software under ISO 15189 and IVDR. Clinical chemistry and laboratory medicine, 2026
- Operationalising digital and AI pathology in translational research and drug development: an infrastructure and regulatory perspective from biobank to companion diagnostic. BMJ oncology, 2026
Compare Healthcare In Vitro Diagnostic side by side
Key companies in Healthcare In Vitro Diagnostic
Roche Diagnostics
Abbott Laboratories
Danaher Corporation
Siemens Healthineers
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company (BD)
bioMérieux SA
Sysmex Corporation
Ortho Clinical Diagnostics
QIAGEN N.V.
Quick answers
How big is the Healthcare In Vitro Diagnostic market?
The world Healthcare In Vitro Diagnostic market was worth about $83.5 Bn in 2023 and is projected to reach $121.2 Bn by 2033, growing 3.8% a year (CAGR).
Which country has the largest Healthcare In Vitro Diagnostic market?
The US is the largest of the 24 countries we cover, at $35.1 Bn in 2023. India grows fastest, at 6.8% a year.
How many clinical trials are running in Healthcare In Vitro Diagnostic?
ClinicalTrials.gov lists 395 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Healthcare In Vitro Diagnostic?
PubMed lists about 1,117 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.